Financial Performance (Q3 2025) - Reported net sales increased by 4.6% to $205.6 million compared to $196.6 million in Q3 2024[2,5] - Pro forma net sales (excluding M6 product lines) increased by 6.3% to $203.4 million compared to $191.3 million in Q3 2024[2] - Bone Growth Therapies net sales increased by 5.7% to $61.2 million[2] - Spinal Implants, Biologics and Enabling Technologies net sales increased by 5.6% to $108.6 million[2] - Global Orthopedics net sales increased by 10.1% to $33.6 million[2] - Adjusted EBITDA increased to $25.114 million, representing 12.2% of reported net sales, compared to $19.180 million or 9.8% in Q3 2024[7] - Pro forma adjusted EBITDA increased to $24.582 million, representing 12.1% of pro forma net sales, compared to $17.515 million in Q3 2024[7] Financial Performance (YTD 2025) - Net sales increased to $602.401 million from $583.834 million[5] - Adjusted EBITDA increased to $55.241 million, representing 9.2% of reported net sales, compared to $43.478 million or 7.4% in YTD 2024[7] - Free cash flow improved to -$18.099 million compared to -$24.285 million in YTD 2024[9] Balance Sheet (September 30, 2025) - Cash and cash equivalents totaled $62.860 million, down from $83.238 million at the end of 2024[3] - Total assets amounted to $832.610 million, compared to $893.294 million at the end of 2024[3]

Company Participation - Aurora Spine Corporation will participate in the Lytham Partners Spring 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on May 29, 2025 [1][2][3] Webcast Details - The webcast presentation is scheduled for 10:15 a.m. ET on May 29, 2025, and will be accessible via the conference homepage or directly through a provided link [2] One-on-One Meetings - Management will engage in virtual one-on-one meetings during the event, with arrangements available through Lytham Partners [3] Company Overview - Aurora Spine focuses on innovative, minimally invasive, regenerative spinal implant technologies aimed at improving spinal surgery outcomes [4]

Core Viewpoint - Aurora Spine Corporation is set to release its financial results for the first quarter of fiscal year 2025 on May 21, 2025, after market hours, with a press release scheduled for May 22, 2025, before market trading [1]. Financial Results Announcement - The financial results for the first quarter ended March 31, 2025, will be filed with SEDAR [1]. - A conference call for investors will take place on May 22, 2025, at 11:00 a.m. ET / 8:00 a.m. PT to discuss the results [2]. Conference Call Details - Interested parties can join the conference call by dialing (844) 861-5497 or (412) 317-5794 [2]. - A live webcast of the conference call will be available at the provided link [2]. Replay Information - A teleconference replay will be accessible until May 29, 2025, with specific access codes provided [3]. - The webcast replay will be available for 90 days at the specified link [3]. Company Overview - Aurora Spine focuses on innovative, minimally invasive, regenerative spinal implant technologies aimed at improving spinal surgery outcomes [4].